F. Matsuzawa

发表

Computational simulation for interactions of nano-molecules: The phospho-pivot modeling algorithm for prediction of interactions between a phospho-protein and its receptor

S. Ohki, M. Eto, F. Matsuzawa, 2005 .

Clinical usefulness of multigene screening with phenotype-driven bioinformatics analysis for the diagnosis of patients with monogenic diabetes or severe insulin resistance.

Keith A. Boroevich, Y. Okada, T. Tsunoda, 2020, Diabetes research and clinical practice.

Diverse incidences of individual oligopeptides (dipeptidic to hexapeptidic) in proteins of human, bakers' yeast, and Escherichia coli origin registered in the Swiss-Prot data base.

H. Doi, S. Ohno, M. Kitajima, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Phospho-pivot modeling predicts specific interactions of protein phosphatase-1 with a phospho-inhibitor protein CPI-17.

S. Ohki, M. Eto, F. Matsuzawa, 2005, Journal of biochemistry.

Critical regions for assembly of vertebrate nonmuscle myosin II.

A. Yamagishi, Masayuki Takahashi, M. Yazawa, 2005, Biochemistry.

A variant in the RP1L1 gene in a family with occult macular dystrophy in a predicted intrinsically disordered region

M. Hiraoka, F. Matsuzawa, S. Aikawa, 2020, Ophthalmic genetics.

Structural and biochemical studies on Pompe disease and a "pseudodeficiency of acid alpha-glucosidase".

S. Tsujino, M. Ikekita, T. Edmunds, 2007, Journal of human genetics.

Three dimensional structural studies of α-N-acetylgalactosaminidase (α-NAGA) in α-NAGA deficiency (Kanzaki disease): different gene mutations cause peculiar structural changes in α-NAGAs resulting in different substrate specificities and clinical phenotypes

H. Doi, T. Kanekura, Y. Hirabayashi, 2005 .

Structural and immunocytochemical studies on α-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease)

H. Doi, H. Nakada, H. Sakuraba, 2004, Journal of Human Genetics.

Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymes

A. Pshezhetsky, H. Doi, J. Kira, 2002, Journal of Human Genetics.

Three dimensional structural studies of alpha-N-acetylgalactosaminidase (alpha-NAGA) in alpha-NAGA deficiency (Kanzaki disease): different gene mutations cause peculiar structural changes in alpha-NAGAs resulting in different substrate specificities and clinical phenotypes.

H. Doi, T. Kanekura, Y. Hirabayashi, 2005, Journal of dermatological science.

Molecular and structural studies of the GM2 gangliosidosis 0 variant

H. Doi, H. Yamada, E. Uyama, 2002, Journal of Human Genetics.

Fabry disease: correlation between structural changes in α-galactosidase, and clinical and biochemical phenotypes

H. Doi, H. Sakuraba, T. Okumiya, 2005, Human Genetics.

Genotype-Structure-Phenotype Correlations of Disease-Associated IGF1R Variants and Similarities to Those of INSR Variants

Y. Okada, T. Tsunoda, T. Kadowaki, 2021, Diabetes.

Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between bcl-2 and tissue failure by E. coli O157:H7.

H. Doi, A. Suzuki, M. Hayashida, 2000, Genes & development.

Structural basis of the GM2 gangliosidosis B variant

H. Doi, H. Sakuraba, A. Tanaka, 2003, Journal of Human Genetics.

Introduction of an N-glycan sequon into HEXA enhances human beta-hexosaminidase cellular uptake in a model of Sandhoff disease.

D. Tsuji, H. Sakuraba, K. Itoh, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Esterification of side-chain oxysterols by lysosomal phospholipase A2.

A. Abe, Y. Niimura, M. Hiraoka, 2020, Biochimica et biophysica acta. Molecular and cell biology of lipids.

Prediction of the mechanism of action of omuralide (clasto-lactacystin beta-lactone) on human cathepsin A based on a structural model of the yeast proteasome beta5/PRE2-subunit/omuralide complex.

H. Doi, K. Itoh, Yoshito Kadota, 2006, Biochimica et biophysica acta.

Microbial serine carboxypeptidase inhibitors--comparative analysis of actions on homologous enzymes derived from man, yeast and wheat.

Hirofumi Doi, Hitoshi Sakuraba, Fumiko Matsuzawa, 2004, The Journal of antibiotics.

Structural and biochemical studies on Pompe disease and a “pseudodeficiency of acid α-glucosidase”

S. Tsujino, M. Ikekita, T. Edmunds, 2007, Journal of Human Genetics.

Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid alpha-glucosidase (alglucosidase alfa): insight into the complex formation mechanism.

M. Ikekita, Toshihide Kobayashi, D. Tsuji, 2008, Clinica chimica acta; international journal of clinical chemistry.

Introduction of an N-Glycan Sequon Into HEXA Enhances Human β-Hexosaminidase Cellular Uptake in a Model of Sandhoff Disease.

D. Tsuji, H. Sakuraba, K. Itoh, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor.

Toshio Kitazawa, S. Ohki, D. Brautigan, 2007, Structure.

Structural modeling and mutagenesis of endo-β-N-acetylglucosaminidase from Ogataea minuta identifies the importance of Trp295 for hydrolytic activity.

Y. Chiba, Xiao-Dong Gao, F. Matsuzawa, 2017, Journal of bioscience and bioengineering.

Inhibitory effects and specificity of synthetic sialyldendrimers toward recombinant human cytosolic sialidase 2 (NEU2).

Kaori Suzuki, D. Tsuji, K. Matsuoka, 2013, Glycobiology.

Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor.

Toshio Kitazawa, S. Ohki, D. Brautigan, 2007, Structure.

Molecular pathologies of and enzyme replacement therapies for lysosomal diseases.

Y. Jigami, Y. Chiba, H. Sakuraba, 2006, CNS & neurological disorders drug targets.